Does PALBOCICLIB Cause Neutrophil count decreased? 2,224 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,224 reports of Neutrophil count decreased have been filed in association with PALBOCICLIB (Ibrance). This represents 2.4% of all adverse event reports for PALBOCICLIB.
2,224
Reports of Neutrophil count decreased with PALBOCICLIB
2.4%
of all PALBOCICLIB reports
126
Deaths
347
Hospitalizations
How Dangerous Is Neutrophil count decreased From PALBOCICLIB?
Of the 2,224 reports, 126 (5.7%) resulted in death, 347 (15.6%) required hospitalization, and 51 (2.3%) were considered life-threatening.
Is Neutrophil count decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 2,224 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Neutrophil count decreased?
CLOZAPINE (2,523)
LENALIDOMIDE (2,471)
CYCLOPHOSPHAMIDE (1,985)
CARBOPLATIN (1,734)
PACLITAXEL (1,562)
RITUXIMAB (1,509)
DEXAMETHASONE (1,320)
BEVACIZUMAB (1,225)
POMALIDOMIDE (1,062)
DOXORUBICIN (972)
Which PALBOCICLIB Alternatives Have Lower Neutrophil count decreased Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID